ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artificial Biological Valve Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-38P17526
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Artificial Biological Valve Market Research Report 2024
BUY CHAPTERS

Global Artificial Biological Valve Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-38P17526
Report
October 2025
Pages:142
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Edwards Lifesciences
Abbott Laboratories
Symetis
Braile Biomedica
Lepu Medical Technology
Colibri Heart Valve

Artificial Biological Valve Market

The global Artificial Biological Valve market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Public Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Artificial Biological Valve leading manufacturers including Boston Scientific, Medtronic, Edwards Lifesciences, Abbott Laboratories, SYMETIS, Braile Biomedica, Lepu Medical Technology, Colibri Heart Valve, etc., dominate supply; the top five capture approximately % of global revenue, with Boston Scientific leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Artificial Biological Valve market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Artificial Biological Valve Market Report

Report Metric Details
Report Name Artificial Biological Valve Market
Segment by Type
  • Bracket Type
  • No Bracket Type
Segment by Application
  • Public Hospital
  • Private Hospital
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boston Scientific, Medtronic, Edwards Lifesciences, Abbott Laboratories, SYMETIS, Braile Biomedica, Lepu Medical Technology, Colibri Heart Valve
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Artificial Biological Valve study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Artificial Biological Valve Market report?

Ans: The main players in the Artificial Biological Valve Market are Boston Scientific, Medtronic, Edwards Lifesciences, Abbott Laboratories, SYMETIS, Braile Biomedica, Lepu Medical Technology, Colibri Heart Valve

What are the Application segmentation covered in the Artificial Biological Valve Market report?

Ans: The Applications covered in the Artificial Biological Valve Market report are Public Hospital, Private Hospital

What are the Type segmentation covered in the Artificial Biological Valve Market report?

Ans: The Types covered in the Artificial Biological Valve Market report are Bracket Type, No Bracket Type

1 Study Coverage
1.1 Introduction to Artificial Biological Valve: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Artificial Biological Valve Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Bracket Type
1.2.3 No Bracket Type
1.3 Market Segmentation by Application
1.3.1 Global Artificial Biological Valve Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Public Hospital
1.3.3 Private Hospital
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Artificial Biological Valve Revenue Estimates and Forecasts 2020-2031
2.2 Global Artificial Biological Valve Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Artificial Biological Valve Sales Estimates and Forecasts 2020-2031
2.4 Global Artificial Biological Valve Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Artificial Biological Valve Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Artificial Biological Valve Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Bracket Type Market Size by Manufacturers
3.5.2 No Bracket Type Market Size by Manufacturers
3.6 Global Artificial Biological Valve Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Artificial Biological Valve Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Artificial Biological Valve Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Artificial Biological Valve Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Artificial Biological Valve Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Artificial Biological Valve Sales and Revenue by Type (2020-2031)
6.4 North America Artificial Biological Valve Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Artificial Biological Valve Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Artificial Biological Valve Sales and Revenue by Type (2020-2031)
7.4 Europe Artificial Biological Valve Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Artificial Biological Valve Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Artificial Biological Valve Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Artificial Biological Valve Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Artificial Biological Valve Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Artificial Biological Valve Sales and Revenue by Type (2020-2031)
9.4 Central and South America Artificial Biological Valve Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Artificial Biological Valve Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Artificial Biological Valve Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Artificial Biological Valve Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Artificial Biological Valve Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Boston Scientific
11.1.1 Boston Scientific Corporation Information
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Artificial Biological Valve Product Models, Descriptions and Specifications
11.1.4 Boston Scientific Artificial Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Boston Scientific Artificial Biological Valve Sales by Product in 2024
11.1.6 Boston Scientific Artificial Biological Valve Sales by Application in 2024
11.1.7 Boston Scientific Artificial Biological Valve Sales by Geographic Area in 2024
11.1.8 Boston Scientific Artificial Biological Valve SWOT Analysis
11.1.9 Boston Scientific Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Artificial Biological Valve Product Models, Descriptions and Specifications
11.2.4 Medtronic Artificial Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Medtronic Artificial Biological Valve Sales by Product in 2024
11.2.6 Medtronic Artificial Biological Valve Sales by Application in 2024
11.2.7 Medtronic Artificial Biological Valve Sales by Geographic Area in 2024
11.2.8 Medtronic Artificial Biological Valve SWOT Analysis
11.2.9 Medtronic Recent Developments
11.3 Edwards Lifesciences
11.3.1 Edwards Lifesciences Corporation Information
11.3.2 Edwards Lifesciences Business Overview
11.3.3 Edwards Lifesciences Artificial Biological Valve Product Models, Descriptions and Specifications
11.3.4 Edwards Lifesciences Artificial Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Edwards Lifesciences Artificial Biological Valve Sales by Product in 2024
11.3.6 Edwards Lifesciences Artificial Biological Valve Sales by Application in 2024
11.3.7 Edwards Lifesciences Artificial Biological Valve Sales by Geographic Area in 2024
11.3.8 Edwards Lifesciences Artificial Biological Valve SWOT Analysis
11.3.9 Edwards Lifesciences Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Corporation Information
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Artificial Biological Valve Product Models, Descriptions and Specifications
11.4.4 Abbott Laboratories Artificial Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Abbott Laboratories Artificial Biological Valve Sales by Product in 2024
11.4.6 Abbott Laboratories Artificial Biological Valve Sales by Application in 2024
11.4.7 Abbott Laboratories Artificial Biological Valve Sales by Geographic Area in 2024
11.4.8 Abbott Laboratories Artificial Biological Valve SWOT Analysis
11.4.9 Abbott Laboratories Recent Developments
11.5 SYMETIS
11.5.1 SYMETIS Corporation Information
11.5.2 SYMETIS Business Overview
11.5.3 SYMETIS Artificial Biological Valve Product Models, Descriptions and Specifications
11.5.4 SYMETIS Artificial Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 SYMETIS Artificial Biological Valve Sales by Product in 2024
11.5.6 SYMETIS Artificial Biological Valve Sales by Application in 2024
11.5.7 SYMETIS Artificial Biological Valve Sales by Geographic Area in 2024
11.5.8 SYMETIS Artificial Biological Valve SWOT Analysis
11.5.9 SYMETIS Recent Developments
11.6 Braile Biomedica
11.6.1 Braile Biomedica Corporation Information
11.6.2 Braile Biomedica Business Overview
11.6.3 Braile Biomedica Artificial Biological Valve Product Models, Descriptions and Specifications
11.6.4 Braile Biomedica Artificial Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Braile Biomedica Recent Developments
11.7 Lepu Medical Technology
11.7.1 Lepu Medical Technology Corporation Information
11.7.2 Lepu Medical Technology Business Overview
11.7.3 Lepu Medical Technology Artificial Biological Valve Product Models, Descriptions and Specifications
11.7.4 Lepu Medical Technology Artificial Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Lepu Medical Technology Recent Developments
11.8 Colibri Heart Valve
11.8.1 Colibri Heart Valve Corporation Information
11.8.2 Colibri Heart Valve Business Overview
11.8.3 Colibri Heart Valve Artificial Biological Valve Product Models, Descriptions and Specifications
11.8.4 Colibri Heart Valve Artificial Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Colibri Heart Valve Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Artificial Biological Valve Industry Chain
12.2 Artificial Biological Valve Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Artificial Biological Valve Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Artificial Biological Valve Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Artificial Biological Valve Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Artificial Biological Valve Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Edwards Lifesciences
Abbott Laboratories
Symetis
Braile Biomedica
Lepu Medical Technology
Colibri Heart Valve
List of Tables
 Table 1. Global Artificial Biological Valve Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Artificial Biological Valve Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Artificial Biological Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Artificial Biological Valve Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Artificial Biological Valve Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Artificial Biological Valve Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Artificial Biological Valve Sales by Region (2020-2025) & (K Units)
 Table 8. Global Artificial Biological Valve Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Artificial Biological Valve Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Artificial Biological Valve Sales Share by Manufacturers (2020-2025)
 Table 12. Global Artificial Biological Valve Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Artificial Biological Valve Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Artificial Biological Valve by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Biological Valve as of 2024)
 Table 16. Global Artificial Biological Valve Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Artificial Biological Valve Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Artificial Biological Valve Manufacturing Base and Headquarters
 Table 19. Global Artificial Biological Valve Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Artificial Biological Valve Sales by Type (2020-2025) & (K Units)
 Table 23. Global Artificial Biological Valve Sales by Type (2026-2031) & (K Units)
 Table 24. Global Artificial Biological Valve Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Artificial Biological Valve Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Artificial Biological Valve ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Artificial Biological Valve Sales by Application (2020-2025) & (K Units)
 Table 29. Global Artificial Biological Valve Sales by Application (2026-2031) & (K Units)
 Table 30. Artificial Biological Valve High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Artificial Biological Valve Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Artificial Biological Valve Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Artificial Biological Valve ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Artificial Biological Valve Growth Accelerators and Market Barriers
 Table 37. North America Artificial Biological Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Artificial Biological Valve Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Artificial Biological Valve Growth Accelerators and Market Barriers
 Table 40. Europe Artificial Biological Valve Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Artificial Biological Valve Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Artificial Biological Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Artificial Biological Valve Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Artificial Biological Valve Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Artificial Biological Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Artificial Biological Valve Investment Opportunities and Key Challenges
 Table 47. Central and South America Artificial Biological Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Artificial Biological Valve Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Artificial Biological Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Boston Scientific Corporation Information
 Table 51. Boston Scientific Description and Major Businesses
 Table 52. Boston Scientific Product Models, Descriptions and Specifications
 Table 53. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Boston Scientific Sales Value Proportion by Product in 2024
 Table 55. Boston Scientific Sales Value Proportion by Application in 2024
 Table 56. Boston Scientific Sales Value Proportion by Geographic Area in 2024
 Table 57. Boston Scientific Artificial Biological Valve SWOT Analysis
 Table 58. Boston Scientific Recent Developments
 Table 59. Medtronic Corporation Information
 Table 60. Medtronic Description and Major Businesses
 Table 61. Medtronic Product Models, Descriptions and Specifications
 Table 62. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Medtronic Sales Value Proportion by Product in 2024
 Table 64. Medtronic Sales Value Proportion by Application in 2024
 Table 65. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 66. Medtronic Artificial Biological Valve SWOT Analysis
 Table 67. Medtronic Recent Developments
 Table 68. Edwards Lifesciences Corporation Information
 Table 69. Edwards Lifesciences Description and Major Businesses
 Table 70. Edwards Lifesciences Product Models, Descriptions and Specifications
 Table 71. Edwards Lifesciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Edwards Lifesciences Sales Value Proportion by Product in 2024
 Table 73. Edwards Lifesciences Sales Value Proportion by Application in 2024
 Table 74. Edwards Lifesciences Sales Value Proportion by Geographic Area in 2024
 Table 75. Edwards Lifesciences Artificial Biological Valve SWOT Analysis
 Table 76. Edwards Lifesciences Recent Developments
 Table 77. Abbott Laboratories Corporation Information
 Table 78. Abbott Laboratories Description and Major Businesses
 Table 79. Abbott Laboratories Product Models, Descriptions and Specifications
 Table 80. Abbott Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Abbott Laboratories Sales Value Proportion by Product in 2024
 Table 82. Abbott Laboratories Sales Value Proportion by Application in 2024
 Table 83. Abbott Laboratories Sales Value Proportion by Geographic Area in 2024
 Table 84. Abbott Laboratories Artificial Biological Valve SWOT Analysis
 Table 85. Abbott Laboratories Recent Developments
 Table 86. SYMETIS Corporation Information
 Table 87. SYMETIS Description and Major Businesses
 Table 88. SYMETIS Product Models, Descriptions and Specifications
 Table 89. SYMETIS Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. SYMETIS Sales Value Proportion by Product in 2024
 Table 91. SYMETIS Sales Value Proportion by Application in 2024
 Table 92. SYMETIS Sales Value Proportion by Geographic Area in 2024
 Table 93. SYMETIS Artificial Biological Valve SWOT Analysis
 Table 94. SYMETIS Recent Developments
 Table 95. Braile Biomedica Corporation Information
 Table 96. Braile Biomedica Description and Major Businesses
 Table 97. Braile Biomedica Product Models, Descriptions and Specifications
 Table 98. Braile Biomedica Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Braile Biomedica Recent Developments
 Table 100. Lepu Medical Technology Corporation Information
 Table 101. Lepu Medical Technology Description and Major Businesses
 Table 102. Lepu Medical Technology Product Models, Descriptions and Specifications
 Table 103. Lepu Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Lepu Medical Technology Recent Developments
 Table 105. Colibri Heart Valve Corporation Information
 Table 106. Colibri Heart Valve Description and Major Businesses
 Table 107. Colibri Heart Valve Product Models, Descriptions and Specifications
 Table 108. Colibri Heart Valve Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Colibri Heart Valve Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Artificial Biological Valve Product Picture
 Figure 2. Global Artificial Biological Valve Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Bracket Type Product Picture
 Figure 4. No Bracket Type Product Picture
 Figure 5. Global Artificial Biological Valve Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Public Hospital
 Figure 7. Private Hospital
 Figure 8. Artificial Biological Valve Report Years Considered
 Figure 9. Global Artificial Biological Valve Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Artificial Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Artificial Biological Valve Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Artificial Biological Valve Revenue Market Share by Region (2020-2031)
 Figure 13. Global Artificial Biological Valve Sales (2020-2031) & (K Units)
 Figure 14. Global Artificial Biological Valve Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 15. Global Artificial Biological Valve Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Artificial Biological Valve Sales Volume Market Share in 2024
 Figure 17. Global Artificial Biological Valve Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Bracket Type Revenue Market Share by Manufacturer in 2024
 Figure 20. No Bracket Type Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Artificial Biological Valve Sales Market Share by Type (2020-2031)
 Figure 22. Global Artificial Biological Valve Revenue Market Share by Type (2020-2031)
 Figure 23. Global Artificial Biological Valve Sales Market Share by Application (2020-2031)
 Figure 24. Global Artificial Biological Valve Revenue Market Share by Application (2020-2031)
 Figure 25. North America Artificial Biological Valve Sales YoY (2020-2031) & (K Units)
 Figure 26. North America Artificial Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Artificial Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 28. North America Artificial Biological Valve Sales Volume (K Units) by Type (2020- 2031)
 Figure 29. North America Artificial Biological Valve Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Artificial Biological Valve Sales Volume (K Units) by Application (2020-2031)
 Figure 31. North America Artificial Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Artificial Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Artificial Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Artificial Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Artificial Biological Valve Sales YoY (2020-2031) & (K Units)
 Figure 36. Europe Artificial Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Artificial Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Artificial Biological Valve Sales Volume (K Units) by Type (2020-2031)
 Figure 39. Europe Artificial Biological Valve Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Artificial Biological Valve Sales Volume (K Units) by Application (2020-2031)
 Figure 41. Europe Artificial Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Artificial Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 43. France Artificial Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Artificial Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Artificial Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Artificial Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Artificial Biological Valve Sales YoY (2020-2031) & (K Units)
 Figure 48. Asia-Pacific Artificial Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Artificial Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Artificial Biological Valve Sales Volume (K Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific Artificial Biological Valve Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Artificial Biological Valve Sales Volume (K Units) by Application (2020-2031)
 Figure 53. Asia-Pacific Artificial Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Artificial Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Artificial Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Artificial Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Artificial Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 58. India Artificial Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Artificial Biological Valve Sales YoY (2020-2031) & (K Units)
 Figure 60. Central and South America Artificial Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Artificial Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Artificial Biological Valve Sales Volume (K Units) by Type (2021-2031)
 Figure 63. Central and South America Artificial Biological Valve Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Artificial Biological Valve Sales Volume (K Units) by Application (2020-2031)
 Figure 65. Central and South America Artificial Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Artificial Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Artificial Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Artificial Biological Valve Sales YoY (2020-2031) & (K Units)
 Figure 69. Middle East and Africa Artificial Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Artificial Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Artificial Biological Valve Sales Volume (K Units) by Type (2021-2031)
 Figure 72. South America Artificial Biological Valve Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Artificial Biological Valve Sales Volume (K Units) by Application (2020-2031)
 Figure 74. Middle East and Africa Artificial Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Artificial Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Artificial Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Artificial Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Artificial Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 79. Artificial Biological Valve Industry Chain Mapping
 Figure 80. Regional Artificial Biological Valve Manufacturing Base Distribution (%)
 Figure 81. Global Artificial Biological Valve Production Market Share by Region (2020-2031)
 Figure 82. Artificial Biological Valve Production Process
 Figure 83. Regional Artificial Biological Valve Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Prescription Drug Acarbose Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-26S19632
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Ifosfamide for Injection Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-30A19656
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Montelukast Sodium Tablet Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-27H17544
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Grade Omega-3 Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-10A20150
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions